CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0001 (18.75%)
Sep 8, 2025, 3:37 PM EDT
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $221.59 thousand as of September 8, 2025. Its market cap has decreased by -5.04% in one year.
Market Cap
221.59K
Enterprise Value
1.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has decreased from 238.06K to 221.59K, a decrease of -6.92%. That is a compound annual growth rate of -0.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 221.59K | -3.75% |
Dec 31, 2024 | 230.22K | -47.89% |
Dec 29, 2023 | 441.78K | -81.12% |
Dec 30, 2022 | 2.34M | -79.95% |
Dec 31, 2021 | 11.67M | -58.56% |
Dec 31, 2020 | 28.16M | 71.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 825.37M |
Elite Pharmaceuticals | 749.52M |
Tian'an Technology Group | 705.53M |
Glass House Brands | 600.85M |
CytoDyn | 396.74M |
Northwest Biotherapeutics | 376.41M |
American Oncology Network | 353.52M |